Healthcare

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

Portfolio News / Jovi Webpuppies

Full Press Release from Biofourmis
BOSTON, July 29, 2021

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure Read More »

Erasca IPOs on Nasdaq

Portfolio News / Jovi Webpuppies

Erasca IPOs on Nasdaq

Erasca IPOs on Nasdaq Read More »

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support

Portfolio News / Jovi Webpuppies

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support Read More »

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

We may use cookies and similar technologies as necessary to run the website and offer you the best possible user experience.
By clicking on "Accept", you consent to the use of all cookies and similar technologies as described in our Privacy Policy.Accept

Healthcare

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

Erasca IPOs on Nasdaq

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support

Join our community!

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

© 2025 EDBI. All rights reserved.